🇺🇸 FDA
Patent

US 6551989

Preventing airway mucus production by administration of EGF-R antagonists

expired A61KA61K31/00A61P

Quick answer

US patent 6551989 (Preventing airway mucus production by administration of EGF-R antagonists) held by The Regents of the University of California expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/00, A61P, A61P11/00, A61P11/02